Lenalidomide in Older Patients With Acute Myeloid Leukemia Without Chromosome 5q Abnormalities
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
This study is designed to test the safety and efficacy of lenalidomide in older patients (age
> 60 years) with untreated acute myeloid leukemia without chromosomal abnormalities involving
5q.